Tokyo, Japan

Shohei Oishi

This inventor holds 3 USPTO granted patents, plus 1 CIPO patent. Top assignees: Tokai Carbon, Daiichi Sankyo Company, Limited. Active years: 2021-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shohei Oishi. Retrieved from https://idiyas.com/inventor/shohei-oishi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 33.3


Average Co-Inventor Count = 4.8

ph-index = 1


Company Filing History:


Years Active: 2021-2026

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovations of Shohei Oishi

Introduction

Shohei Oishi is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of molecular biology and pharmaceuticals. His innovative work has led to the development of a unique molecular conjugate that holds promise for medical applications.

Latest Patents

Oishi holds a patent for a HANP-Fc-containing molecular conjugate. This invention provides a conjugate comprising a hANP peptide bonded via a polyethylene glycol linker to a glycan attached to Asn297 of a Fc-containing molecule (N297 glycan), or a pharmaceutically acceptable salt thereof. The patent also includes a medicament comprising the same as an active ingredient, along with a method for producing the same.

Career Highlights

Shohei Oishi is currently employed at Daiichi Sankyo Company, Limited, where he continues to advance his research and development efforts. His work is characterized by a commitment to innovation and excellence in the pharmaceutical industry.

Collaborations

Oishi has collaborated with notable colleagues, including Mitsuhiro Iwamoto and Yukiko Sekiguchi. These partnerships have fostered a collaborative environment that enhances the potential for groundbreaking discoveries.

Conclusion

Shohei Oishi's contributions to the field of molecular biology and his innovative patent demonstrate his dedication to advancing medical science. His work at Daiichi Sankyo Company, Limited, along with his collaborations, positions him as a key figure in the ongoing pursuit of medical advancements.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…